Treatment of factor VII deficiency with recombinant factor VIIa

Haemostasis. 1996;26 Suppl 1:155-8. doi: 10.1159/000217259.


Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIIa has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VII-deficient patients with a therapeutic agent that is not derived from human plasma.

Publication types

  • Review

MeSH terms

  • Factor VII Deficiency / drug therapy*
  • Factor VIIa / therapeutic use*
  • Hemorrhage / drug therapy*
  • Humans
  • Recombinant Proteins / therapeutic use


  • Recombinant Proteins
  • Factor VIIa